Pancreatic Cancer Cells and EGF Receptor Pathway
Author Information
Author(s): Murphy L O, Cluck M W, Lovas S, Ötvös F, Murphy R F, Schally A V, Permert J, Larsson J, Knezetic J A, Adrian T E
Primary Institution: Department of Biomedical Sciences, Creighton University School of Medicine
Hypothesis
Do pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions?
Conclusion
The study found that pancreatic cancer cells rely on the EGF receptor for sustained growth in serum-free conditions.
Supporting Evidence
- The study identified a functional autocrine growth pathway in pancreatic cancer.
- Proliferation was greater when pancreatic cancer cells were grown without changing the medium.
- The EGF receptor and the ERK MAP kinase pathway mediate autocrine signals in pancreatic cancer cells.
Takeaway
Pancreatic cancer cells need a special signal from their own growth factors to keep growing when there's no serum around.
Methodology
In-vitro cell culture studies were conducted to assess the role of autocrine pathways in pancreatic cancer cell proliferation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website